瀏覽其他金融產品
INCYIncyte Corporation
Incyte Corporation
INCY重點摘要
最後更新: 2026-07-28- •Incyte Q2 non-GAAP EPS of $3.09 beat estimates by ~$0.94; revenue of $1.67B beat by ~$180M — among the larger earnings surprises in the current cycle.
- •Full-year guidance disappointed some analysts even as the company raised its sales outlook, explaining the muted/slightly negative stock reaction despite the beat.
- •Leverage traders on INCY CFDs face a two-sided risk: the EPS beat supports upside, but guidance concerns cap it — at 50x leverage, a 3% move equals 150% margin return or loss.
- •Cross-market impact is limited to healthcare/biotech ETFs (XBI, XLV); broad indices (S&P 500, NASDAQ-100) see minimal spillover.
- •The beat-but-guide-down pattern is a recurring theme in Q2 2026 earnings season — position sizing discipline and post-earnings price action confirmation are critical before adding leverage.
價格及市場結構
市況形態狀態
術語表
關鍵上市股票與 CFD 詞彙,每個一句 —— 令頁面對讀者同 AI 引擎都清晰無歧義。
| 股票差價合約 | 針對股價的差價合約 —— 僅取得價格敞口,並不擁有相關股份。 |
|---|---|
| 延長時段 | 在交易所常規時段以外的盤前及盤後交易。 |
| 基差風險 | 差價合約參考價與交易所成交價未必同步變動的風險。 |
| 市盈率 | 市盈率 = 股價 ÷ 每股盈利;常用的估值指標。 |
| 毛利率 | 毛利 ÷ 營收;反映產品層面的盈利能力。 |
| 每股盈利 | 每股盈利 = 淨利潤 ÷ 攤薄後流通股數。 |
最新動態
Incyte Q2 Earnings Smash: $3.09 EPS Beats by $0.94, But Guidance Miss Creates a Two-Sided CFD Trade
Incyte Corporation (NASDAQ: INCY) reported Q2 non-GAAP EPS of $3.09, beating consensus estimates by approximately $0.94, and revenue of $1.67 billion, surpassing analyst expectations by roughly $180 m
Incyte Acquires Vega Therapeutics for $1.25B — Hematology Bet Deepens Biotech M&A Wave
Incyte Corporation (NASDAQ: INCY) has announced the acquisition of Vega Therapeutics, a privately held hematology-focused biotech developed within the Star Therapeutics company-creation platform, for
Incyte 約 20 億美元收購 Star Therapeutics:槓桿情境與生技併購解讀
根據《金融時報》報導,Incyte Corporation (INCY) 即將以約 20 億美元的價格收購一家私營血液疾病藥物開發商 Star Therapeutics。此交易尚未獲得雙方公司正式確認,但《金融時報》的消息來源 — 通常基於熟悉內情人士 — 在事件驅動型市場中被視為高度可信。Star Therapeutics 專注於血液學/罕見血液疾病,與 Incyte 現有的腫瘤學和血液學業務相
Get Started with Incyte Corporation
Start trading Incyte Corporation on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade INCY CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Incyte Corporation: Step-by-Step Guide
Learn how to trade Incyte Corporation (INCY) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find INCY in the Stocks Section
Navigate to the stocks market section and search for INCY. You can trade Incyte Corporation as a CFD with up to 1000x leverage.
- ✓Search for "INCY" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Incyte Corporation.
- ✓Long (buy) if you expect INCY to rise
- ✓Short (sell) if you expect INCY to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
標籤
Similar Stocks Assets
Explore other stocks instruments in the same sector as Incyte Corporation. Compare performance and find trading opportunities.

Tempus AI, Inc

Estee Lauder

Hecla Mining Company

Coeur Mining, Inc.

Kinross Gold Corporation
免責聲明與參考資料
重要風險提示
CoinUnited 股票差價合約只提供 Incyte Corporation 的價格敞口,並非股權擁有:沒有股東投票權、沒有股息,亦不會以相關股票交收。
槓桿同時放大虧損與盈利,部位可能在相關股價回升之前已被強制平倉。相關股票按交易所時段掛牌,參考價可能在時段之間跳空。
用戶在作出任何投資決策前,應自行研究並諮詢合資格的財務專業人士。本平台之創建者及營運者概不承擔因依賴相關資訊而導致的任何財務損失或其他損害責任。
槓桿交易風險極高,可能損失全部本金。
方法論概覽
本頁數據來自一手及具名第三方來源,並非由預測模型產生。每一項的來源與日期均列於上方的出處對照表。
- 財務報表:公司自身的 SEC 申報文件(10-K/10-Q),由 XBRL 讀取
- 市場數據:CoinUnited 參考價及每日收市價
- 機構持股:SEC Form 13F 季度申報
- 分析師目標價:聚合的第三方賣方研究 — 屬第三方意見,並非 CoinUnited 觀點
- 同業倍數:第三方過去十二個月比率
CoinUnited 不會就 Incyte Corporation 發布價格預測或目標價。
方法論最後審閱日期:
準備好開始交易 Incyte Corporation 了嗎?
加入數千名交易者,今天就開始您的 Incyte Corporation 交易之旅。獲得先進的交易工具和具競爭力的費用。



